Retractable Technologies, Inc. (RVP)
- Previous Close
1.0800 - Open
1.0700 - Bid 1.0600 x 1400
- Ask 1.0700 x 800
- Day's Range
1.0600 - 1.0702 - 52 Week Range
0.9500 - 1.8500 - Volume
29,843 - Avg. Volume
76,335 - Market Cap (intraday)
31.733M - Beta (5Y Monthly) 2.10
- PE Ratio (TTM)
-- - EPS (TTM)
-0.2400 - Earnings Date May 13, 2024 - May 17, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.
www.retractable.comRecent News: RVP
Performance Overview: RVP
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RVP
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RVP
Valuation Measures
Market Cap
32.33M
Enterprise Value
-13.19M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.74
Price/Book (mrq)
0.33
Enterprise Value/Revenue
-0.30
Enterprise Value/EBITDA
10.66
Financial Highlights
Profitability and Income Statement
Profit Margin
-16.08%
Return on Assets (ttm)
-3.83%
Return on Equity (ttm)
-6.81%
Revenue (ttm)
43.6M
Net Income Avi to Common (ttm)
-7.24M
Diluted EPS (ttm)
-0.2400
Balance Sheet and Cash Flow
Total Cash (mrq)
47.29M
Total Debt/Equity (mrq)
1.55%
Levered Free Cash Flow (ttm)
5.69M